Unichem gets USFDA’s nod for Solifenacin Succinate Tablets

28 Aug 2019

Unichem Laboratories has received ANDA approval from the United States Food and Drug Administration (USFDA) for Solifenacin Succinate Tablets, 5 mg and 10 mg to market a generic version of Vesicare Tablets, 5 mg and 10 mg, of Astellas Pharma US, Inc. which are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. The product will be commercialized from company’s Goa plant.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world.

Related Unichem Laboratories Ltd. Links:

Unichem Lab Share Price

342.55 12.20 (3.69%) May 10, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 698.15
Dr. Reddys Lab 5329.10
Lupin 1222.80
Piramal Enterprises 1705.90
Cadila Healthcare 624.00
View more..
Sensex vs Unichem Lab
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback